Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CACNA1C: Association With Psychiatric Disorders, Behavior, and Neurogenesis
Anna Moon, Niels Haan, Lawrence S. Wilkinson, et al.
Schizophrenia Bulletin (2018) Vol. 44, Iss. 5, pp. 958-965
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Robust Hi-C Maps of Enhancer-Promoter Interactions Reveal the Function of Non-coding Genome in Neural Development and Diseases
Leina Lu, Xiaoxiao Liu, Wei‐Kai Huang, et al.
Molecular Cell (2020) Vol. 79, Iss. 3, pp. 521-534.e15
Open Access | Times Cited: 140
Autism spectrum disorder and schizophrenia: An updated conceptual review
Amandeep Jutla, Jennifer H. Foss‐Feig, Jeremy Veenstra‐VanderWeele
Autism Research (2021) Vol. 15, Iss. 3, pp. 384-412
Open Access | Times Cited: 89
Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale
James S. W. Hong, Lauren Atkinson, Noura Al‐Juffali, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 3, pp. 1339-1349
Open Access | Times Cited: 74
Calcium channelopathies and intellectual disability: a systematic review
Miriam Kessi, Baiyu Chen, Jing Peng, et al.
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 58
Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders
Judit Cabana‐Domínguez, Bàrbara Torrico, Andreas Reif, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders
Jiewei Liu, Yuqi Cheng, Ming Li, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 2, pp. 270-280
Open Access | Times Cited: 45
Improved functional mapping of complex trait heritability with GSA-MiXeR implicates biologically specific gene sets
Oleksandr Frei, Guy Hindley, Alexey Shadrin, et al.
Nature Genetics (2024) Vol. 56, Iss. 6, pp. 1310-1318
Closed Access | Times Cited: 11
Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations
Bohan Fan, Jie Zhao
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons—A Comprehensive Review
Antea Kršek, Leona Ostojić, Dorotea Zivalj, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9695-9695
Open Access | Times Cited: 7
Biophysical classification of a CACNA1D de novo mutation as a high-risk mutation for a severe neurodevelopmental disorder
Nadja T. Hofer, Petronel Tuluc, Nadine J. Ortner, et al.
Molecular Autism (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 45
Neuronal L-Type Calcium Channel Signaling to the Nucleus Requires a Novel CaMKIIα-Shank3 Interaction
Tyler L. Perfitt, Xiaohan Wang, Matthew T. Dickerson, et al.
Journal of Neuroscience (2020) Vol. 40, Iss. 10, pp. 2000-2014
Open Access | Times Cited: 44
Update on the Molecular Genetics of Timothy Syndrome
Rosemary Bauer, Katherine W. Timothy, Andy Golden
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 41
Parallel functional testing identifies enhancers active in early postnatal mouse brain
Jason T. Lambert, Linda Su-Feher, Karol Cichewicz, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 33
Voltage-gated calcium channel blockers for psychiatric disorders: genomic reappraisal
Paul J. Harrison, Elizabeth M. Tunbridge, Annette Dolphin, et al.
The British Journal of Psychiatry (2019) Vol. 216, Iss. 5, pp. 250-253
Open Access | Times Cited: 40
Downregulation of neurodevelopmental gene expression in iPSC-derived cerebral organoids upon infection by human cytomegalovirus
Benjamin S. O’Brien, Rebekah L. Mokry, Megan L. Schumacher, et al.
iScience (2022) Vol. 25, Iss. 4, pp. 104098-104098
Open Access | Times Cited: 22
CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology
Paul J. Harrison, Syed Masood Husain, Hami Lee, et al.
Neuropharmacology (2022) Vol. 220, pp. 109262-109262
Open Access | Times Cited: 21
CaMKK2 as an emerging treatment target for bipolar disorder
Jacqueline Kaiser, Kévin Nay, Christopher R. Horne, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 11, pp. 4500-4511
Open Access | Times Cited: 11
Cav1.2 channelopathies causing autism: new hallmarks on Timothy syndrome
Andrea Marcantoni, Chiara Calorio, Enis Hidişoğlu, et al.
Pflügers Archiv - European Journal of Physiology (2020) Vol. 472, Iss. 7, pp. 775-789
Closed Access | Times Cited: 32
Effects of Cacna1c haploinsufficiency on social interaction behavior and 50-kHz ultrasonic vocalizations in adult female rats
Tobias M. Redecker, Theresa M. Kisko, Rainer K.W. Schwarting, et al.
Behavioural Brain Research (2019) Vol. 367, pp. 35-52
Closed Access | Times Cited: 31
Longitudinal genome-wide methylation study of PTSD treatment using prolonged exposure and hydrocortisone
Ruoting Yang, Changxin Xu, Linda M. Bierer, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27
Neurotrophin receptor activation rescues cognitive and synaptic abnormalities caused by hemizygosity of the psychiatric risk gene Cacna1c
Cezar M. Tigaret, Tzu‐Ching E. Lin, Edward Morrell, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 6, pp. 1748-1760
Open Access | Times Cited: 26
Targeting synaptic plasticity in schizophrenia: insights from genomic studies
Arne W. Mould, Nicola Hall, Ira Milošević, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 11, pp. 1022-1032
Closed Access | Times Cited: 26
Haploinsufficiency of the schizophrenia and autism risk gene Cyfip1 causes abnormal postnatal hippocampal neurogenesis through microglial and Arp2/3 mediated actin dependent mechanisms
Niels Haan, Laura J. Westacott, Jenny Carter, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Deep learning predicts DNA methylation regulatory variants in the human brain and elucidates the genetics of psychiatric disorders
Jiyun Zhou, Qiang Chen, Patricia Braun, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 34
Open Access | Times Cited: 18
Molecular and Cellular Mechanisms of Bipolar Disorder
Colleen A. McClung, Hilary P. Blumberg
Oxford University Press eBooks (2025), pp. 301-316
Closed Access
Page 1 - Next Page

Scroll to top